Abstract
Objective
Previous research indicates a rise in adult opioid misuse due to childhood opioid use. This study seeks to identify patient-specific features associated with postoperative opioid prescriptions at discharge in pediatric plastic surgery patients.
Design
Single-institution, retrospective review.
Setting
Level 1 Pediatric Surgery Center.
Patients, Participants
Patients under 18 years old who underwent surgery by a single pediatric plastic surgeon between January 2020 and November 2022 (N = 429).
Intervention
Surgery by a plastic surgeon.
Main Outcome Measure
Presence of an active opioid prescription at hospital discharge.
Results
In total, 429 patients were analyzed. Upon multivariate analysis, opioid use in inpatient setting (aOR: 4.310; 95% CI: 1.035-17.960; P = .045), private insurance (aOR: 2.031; 95% CI: 1.071-3.854; P = .030), prior surgical history (aOR: 2.015; 95% CI: 1.089-3.726; P = .026), increased age (aOR: 1.164; 95% CI: 1.101-1.230; P < .001), and increased operative time (aOR: 1.016; 95% CI: 1.012-1.020; P < .001) independently increased the odds of having an opioid prescription at discharge. Patients that underwent cleft palate procedures (aOR: 2.299; 95% CI: 1.124-4.702; P = .023) or breast procedures (aOR: 6.768; 95% CI: 1.293-35.425; P = .024) had increased odds of an opioid prescription at discharge. Patients undergoing cutaneous procedures experienced decreased odds of an opioid prescription at discharge (aOR: 0.206; 95% CI: 0.081-0.528; P = .001).
Conclusions
Patient-specific features, including demographic and clinical characteristics, were identified as independent predictors of opioid prescription at discharge in this pediatric plastic surgery patient population.
Get full access to this article
View all access options for this article.
